FRAMINGHAM, Mass.--PE Biosystems said it will form a center for proteomics research at its PerSeptive Biosystems division here. The Proteomics Research Center will develop novel tools for proteomics, advance the science of proteomics, and create practical application-based systems for research, drug discovery and development, and health care.
PE Biosystems will develop value-added systems and Celera Genomics will generate protein information to give the proteomics effort a boost, said Tony White, PE’s chairman, president, and CEO. The proteomics center will use PerSeptive’s mass spectrometry technology along with products from other PE Biosystems divisions.
As part of the proteomics initiative, PE Biosystems has begun research collaborations with the University of Geneva and the University of Washington in Seattle to develop new proteomics technologies.